1st Quarter - Amendment

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$2,890,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 19, 2013 $4,190,000 Replaced
1st Quarter - Amendment (this page) Oct 21, 2013 $2,890,000 Yes

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Deficit reduction (no specific bill); ADAP funding (no specific bill)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent settlements (no specific bill)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Alzheimer's education (no specific bill); 340b (no specific bill); hepatitis C education (no specific bill).

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Trans-Pacific Partnership (no specific bill); biologic data exclusivity (no specific bill); US-EU trade agreement (no specific bill); trade promotion authority (no specific bill)

LobbyistCovered position, as disclosed
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Manufacturing MAN

Supply chain safety (no specific bills)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 351 (113th), H.R. 351 (113th)

Consumer Issues/Safety/Products CSP

Access to over-the-counter medications (no specific bill); compounding (no specific bill)

LobbyistCovered position, as disclosed
JENNIFER HAWKS BLAND —
ELI JOSEPH —
ERIN POLAK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Animal Drug User Fee Act (ADUFA)

LobbyistCovered position, as disclosed
ERIN POLAK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.